nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Dactinomycin—testicular cancer	0.378	0.602	CbGbCtD
Ipratropium bromide—CYP3A4—Ifosfamide—testicular cancer	0.068	0.108	CbGbCtD
Ipratropium bromide—CYP2D6—Vinblastine—testicular cancer	0.0567	0.0902	CbGbCtD
Ipratropium bromide—CYP3A4—Vinblastine—testicular cancer	0.0361	0.0574	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—testicular cancer	0.0348	0.0554	CbGbCtD
Ipratropium bromide—CYP3A4—Etoposide—testicular cancer	0.0325	0.0517	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—testicular cancer	0.0222	0.0352	CbGbCtD
Ipratropium bromide—Infection—Etoposide—testicular cancer	0.000685	0.00185	CcSEcCtD
Ipratropium bromide—Asthenia—Dactinomycin—testicular cancer	0.000684	0.00184	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—testicular cancer	0.00068	0.00183	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—testicular cancer	0.00068	0.00183	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—testicular cancer	0.00068	0.00183	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—testicular cancer	0.00068	0.00183	CcSEcCtD
Ipratropium bromide—Paraesthesia—Cisplatin—testicular cancer	0.000676	0.00182	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000675	0.00182	CcSEcCtD
Ipratropium bromide—Tachycardia—Etoposide—testicular cancer	0.000673	0.00181	CcSEcCtD
Ipratropium bromide—Dyspnoea—Cisplatin—testicular cancer	0.000671	0.00181	CcSEcCtD
Ipratropium bromide—Skin disorder—Etoposide—testicular cancer	0.00067	0.0018	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Etoposide—testicular cancer	0.000667	0.0018	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—testicular cancer	0.000654	0.00176	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dactinomycin—testicular cancer	0.000652	0.00176	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00065	0.00175	CcSEcCtD
Ipratropium bromide—Vomiting—Bleomycin—testicular cancer	0.00065	0.00175	CcSEcCtD
Ipratropium bromide—Hypotension—Etoposide—testicular cancer	0.000645	0.00174	CcSEcCtD
Ipratropium bromide—Rash—Bleomycin—testicular cancer	0.000644	0.00174	CcSEcCtD
Ipratropium bromide—Pain—Cisplatin—testicular cancer	0.000644	0.00173	CcSEcCtD
Ipratropium bromide—Dermatitis—Bleomycin—testicular cancer	0.000644	0.00173	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ifosfamide—testicular cancer	0.000644	0.00173	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—testicular cancer	0.000636	0.00171	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000632	0.0017	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—testicular cancer	0.000632	0.0017	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—testicular cancer	0.00063	0.0017	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—testicular cancer	0.000629	0.00169	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—testicular cancer	0.000629	0.00169	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—testicular cancer	0.000629	0.00169	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—testicular cancer	0.000628	0.00169	CcSEcCtD
Ipratropium bromide—Asthenia—Ifosfamide—testicular cancer	0.000627	0.00169	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—testicular cancer	0.000621	0.00167	CcSEcCtD
Ipratropium bromide—Paraesthesia—Etoposide—testicular cancer	0.00062	0.00167	CcSEcCtD
Ipratropium bromide—Pruritus—Ifosfamide—testicular cancer	0.000618	0.00166	CcSEcCtD
Ipratropium bromide—Dyspnoea—Etoposide—testicular cancer	0.000615	0.00166	CcSEcCtD
Ipratropium bromide—Somnolence—Etoposide—testicular cancer	0.000613	0.00165	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—testicular cancer	0.000611	0.00165	CcSEcCtD
Ipratropium bromide—Nausea—Bleomycin—testicular cancer	0.000607	0.00163	CcSEcCtD
Ipratropium bromide—Vomiting—Dactinomycin—testicular cancer	0.000606	0.00163	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—testicular cancer	0.000605	0.00163	CcSEcCtD
Ipratropium bromide—Rash—Dactinomycin—testicular cancer	0.000601	0.00162	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ifosfamide—testicular cancer	0.000598	0.00161	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000596	0.0016	CcSEcCtD
Ipratropium bromide—Fatigue—Etoposide—testicular cancer	0.000595	0.0016	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—testicular cancer	0.000594	0.0016	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—testicular cancer	0.000591	0.00159	CcSEcCtD
Ipratropium bromide—Pain—Etoposide—testicular cancer	0.00059	0.00159	CcSEcCtD
Ipratropium bromide—Constipation—Etoposide—testicular cancer	0.00059	0.00159	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—testicular cancer	0.000589	0.00159	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—testicular cancer	0.000589	0.00159	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—testicular cancer	0.000588	0.00158	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000585	0.00157	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—testicular cancer	0.000585	0.00157	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—testicular cancer	0.000582	0.00157	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—testicular cancer	0.000581	0.00157	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—testicular cancer	0.000581	0.00157	CcSEcCtD
Ipratropium bromide—Dizziness—Ifosfamide—testicular cancer	0.000578	0.00156	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—testicular cancer	0.000577	0.00155	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—testicular cancer	0.000574	0.00155	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—testicular cancer	0.000572	0.00154	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—testicular cancer	0.00057	0.00154	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—testicular cancer	0.000569	0.00153	CcSEcCtD
Ipratropium bromide—Nausea—Dactinomycin—testicular cancer	0.000566	0.00152	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Etoposide—testicular cancer	0.000564	0.00152	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—testicular cancer	0.000561	0.00151	CcSEcCtD
Ipratropium bromide—Vomiting—Ifosfamide—testicular cancer	0.000555	0.0015	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Cisplatin—testicular cancer	0.000555	0.00149	CcSEcCtD
Ipratropium bromide—Rash—Ifosfamide—testicular cancer	0.000551	0.00148	CcSEcCtD
Ipratropium bromide—Dermatitis—Ifosfamide—testicular cancer	0.00055	0.00148	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00055	0.00148	CcSEcCtD
Ipratropium bromide—Urticaria—Etoposide—testicular cancer	0.000548	0.00148	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—testicular cancer	0.000547	0.00147	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—testicular cancer	0.000547	0.00147	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—testicular cancer	0.000546	0.00147	CcSEcCtD
Ipratropium bromide—Abdominal pain—Etoposide—testicular cancer	0.000545	0.00147	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—testicular cancer	0.000545	0.00147	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—testicular cancer	0.000545	0.00147	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—testicular cancer	0.000544	0.00147	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—testicular cancer	0.000544	0.00146	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—testicular cancer	0.000542	0.00146	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—testicular cancer	0.000542	0.00146	CcSEcCtD
Ipratropium bromide—Asthenia—Cisplatin—testicular cancer	0.00054	0.00145	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—testicular cancer	0.00054	0.00145	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—testicular cancer	0.00054	0.00145	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—testicular cancer	0.000538	0.00145	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—testicular cancer	0.000538	0.00145	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—testicular cancer	0.000534	0.00144	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—testicular cancer	0.000529	0.00142	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—testicular cancer	0.000526	0.00142	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—testicular cancer	0.000525	0.00141	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—testicular cancer	0.000525	0.00141	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—testicular cancer	0.000524	0.00141	CcSEcCtD
Ipratropium bromide—Nausea—Ifosfamide—testicular cancer	0.000519	0.0014	CcSEcCtD
Ipratropium bromide—Diarrhoea—Cisplatin—testicular cancer	0.000515	0.00139	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—testicular cancer	0.000509	0.00137	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Etoposide—testicular cancer	0.000508	0.00137	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—testicular cancer	0.000508	0.00137	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—testicular cancer	0.000506	0.00136	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—testicular cancer	0.000505	0.00136	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—testicular cancer	0.000505	0.00136	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—testicular cancer	0.000505	0.00136	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—testicular cancer	0.000504	0.00136	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—testicular cancer	0.000501	0.00135	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—testicular cancer	0.0005	0.00135	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000497	0.00134	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—testicular cancer	0.000496	0.00134	CcSEcCtD
Ipratropium bromide—Asthenia—Etoposide—testicular cancer	0.000495	0.00133	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—testicular cancer	0.000494	0.00133	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—testicular cancer	0.000492	0.00132	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—testicular cancer	0.000491	0.00132	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—testicular cancer	0.00049	0.00132	CcSEcCtD
Ipratropium bromide—Pruritus—Etoposide—testicular cancer	0.000488	0.00131	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—testicular cancer	0.000485	0.00131	CcSEcCtD
Ipratropium bromide—Vomiting—Cisplatin—testicular cancer	0.000479	0.00129	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—testicular cancer	0.000477	0.00128	CcSEcCtD
Ipratropium bromide—Rash—Cisplatin—testicular cancer	0.000475	0.00128	CcSEcCtD
Ipratropium bromide—Dermatitis—Cisplatin—testicular cancer	0.000474	0.00128	CcSEcCtD
Ipratropium bromide—Diarrhoea—Etoposide—testicular cancer	0.000472	0.00127	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—testicular cancer	0.000471	0.00127	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—testicular cancer	0.00047	0.00126	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—testicular cancer	0.000467	0.00126	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—testicular cancer	0.000467	0.00126	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—testicular cancer	0.000467	0.00126	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—testicular cancer	0.000465	0.00125	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—testicular cancer	0.000464	0.00125	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—testicular cancer	0.00046	0.00124	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—testicular cancer	0.000458	0.00123	CcSEcCtD
Ipratropium bromide—Dizziness—Etoposide—testicular cancer	0.000456	0.00123	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—testicular cancer	0.000455	0.00122	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—testicular cancer	0.000454	0.00122	CcSEcCtD
Ipratropium bromide—Nausea—Cisplatin—testicular cancer	0.000447	0.0012	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—testicular cancer	0.000447	0.0012	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—testicular cancer	0.000442	0.00119	CcSEcCtD
Ipratropium bromide—Vomiting—Etoposide—testicular cancer	0.000439	0.00118	CcSEcCtD
Ipratropium bromide—Rash—Etoposide—testicular cancer	0.000435	0.00117	CcSEcCtD
Ipratropium bromide—Dermatitis—Etoposide—testicular cancer	0.000435	0.00117	CcSEcCtD
Ipratropium bromide—Headache—Etoposide—testicular cancer	0.000432	0.00116	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—testicular cancer	0.000432	0.00116	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—testicular cancer	0.000431	0.00116	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—testicular cancer	0.000431	0.00116	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—testicular cancer	0.00043	0.00116	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—testicular cancer	0.000429	0.00116	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000428	0.00115	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—testicular cancer	0.000426	0.00115	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—testicular cancer	0.000424	0.00114	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—testicular cancer	0.000419	0.00113	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—testicular cancer	0.000413	0.00111	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—testicular cancer	0.000413	0.00111	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—testicular cancer	0.000413	0.00111	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—testicular cancer	0.000411	0.00111	CcSEcCtD
Ipratropium bromide—Nausea—Etoposide—testicular cancer	0.00041	0.0011	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—testicular cancer	0.000409	0.0011	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—testicular cancer	0.000405	0.00109	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—testicular cancer	0.000403	0.00109	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—testicular cancer	0.000403	0.00109	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—testicular cancer	0.000401	0.00108	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000401	0.00108	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—testicular cancer	0.000399	0.00108	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—testicular cancer	0.000395	0.00106	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—testicular cancer	0.000387	0.00104	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—testicular cancer	0.000387	0.00104	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—testicular cancer	0.000387	0.00104	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—testicular cancer	0.000386	0.00104	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—testicular cancer	0.000384	0.00103	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—testicular cancer	0.000383	0.00103	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—testicular cancer	0.000379	0.00102	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—testicular cancer	0.000379	0.00102	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—testicular cancer	0.000377	0.00102	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000376	0.00101	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—testicular cancer	0.000376	0.00101	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—testicular cancer	0.000374	0.00101	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—testicular cancer	0.000374	0.00101	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—testicular cancer	0.000373	0.00101	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—testicular cancer	0.000373	0.00101	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—testicular cancer	0.000371	0.000999	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000371	0.000998	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—testicular cancer	0.000368	0.000992	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—testicular cancer	0.000367	0.000989	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—testicular cancer	0.000365	0.000983	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—testicular cancer	0.000364	0.000979	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—testicular cancer	0.000361	0.000973	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—testicular cancer	0.000358	0.000963	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—testicular cancer	0.000358	0.000963	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000357	0.000961	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—testicular cancer	0.000356	0.000959	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—testicular cancer	0.000355	0.000957	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—testicular cancer	0.000353	0.000952	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000352	0.000949	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—testicular cancer	0.000351	0.000945	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—testicular cancer	0.00035	0.000942	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—testicular cancer	0.000349	0.00094	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—testicular cancer	0.000348	0.000936	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—testicular cancer	0.000347	0.000935	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000346	0.000931	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—testicular cancer	0.000345	0.000928	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—testicular cancer	0.000344	0.000926	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—testicular cancer	0.00034	0.000917	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000338	0.00091	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—testicular cancer	0.000334	0.0009	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000334	0.000899	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—testicular cancer	0.000333	0.000898	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—testicular cancer	0.000331	0.00089	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—testicular cancer	0.000331	0.00089	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—testicular cancer	0.000328	0.000884	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—testicular cancer	0.000327	0.00088	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000326	0.000878	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—testicular cancer	0.000324	0.000871	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—testicular cancer	0.000321	0.000865	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—testicular cancer	0.000319	0.000859	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—testicular cancer	0.000318	0.000857	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000316	0.000851	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—testicular cancer	0.000315	0.000848	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000309	0.000832	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—testicular cancer	0.000309	0.000831	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—testicular cancer	0.000307	0.000827	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—testicular cancer	0.000306	0.000824	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—testicular cancer	0.000306	0.000824	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—testicular cancer	0.000306	0.000823	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—testicular cancer	0.000304	0.00082	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—testicular cancer	0.000296	0.000798	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000293	0.000788	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—testicular cancer	0.000292	0.000787	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—testicular cancer	0.000285	0.000767	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—testicular cancer	0.000284	0.000765	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—testicular cancer	0.000283	0.000762	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—testicular cancer	0.000283	0.000761	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—testicular cancer	0.000277	0.000747	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—testicular cancer	0.000274	0.000737	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—testicular cancer	0.000273	0.000736	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—testicular cancer	0.000265	0.000712	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—testicular cancer	0.000264	0.00071	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—testicular cancer	0.000263	0.000707	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—testicular cancer	0.000261	0.000702	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—testicular cancer	0.00026	0.000701	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—testicular cancer	0.000259	0.000697	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—testicular cancer	0.000257	0.000691	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—testicular cancer	0.000256	0.000689	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—testicular cancer	0.000253	0.000682	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—testicular cancer	0.000246	0.000662	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—testicular cancer	0.000245	0.000661	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—testicular cancer	0.000245	0.000659	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—testicular cancer	0.000244	0.000657	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—testicular cancer	0.000244	0.000656	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—testicular cancer	0.000242	0.000652	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—testicular cancer	0.000237	0.000637	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—testicular cancer	0.00023	0.000619	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—testicular cancer	0.000228	0.000613	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—testicular cancer	0.000226	0.000607	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—testicular cancer	0.000225	0.000607	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—testicular cancer	0.000224	0.000604	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—testicular cancer	0.000213	0.000572	CcSEcCtD
